Novel SCN9A variant associated with congenital insensitivity to pain

[1]  E. Salvi,et al.  Congenital insensitivity to pain: a novel mutation affecting a U12-type intron causes multiple aberrant splicing of SCN9A , 2021, Pain.

[2]  S. Züchner,et al.  Rare mutations in ATL3, SPTLC2 and SCN9A explaining hereditary sensory neuropathy and congenital insensitivity to pain in a Brazilian cohort , 2021, Journal of the Neurological Sciences.

[3]  C. Haaxma,et al.  Novel SCN9A Mutations in a Compound Heterozygous Girl with Congenital Insensitivity to Pain , 2020, Journal of Pediatric Neurology.

[4]  M. Nassar,et al.  Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels , 2020, Pflügers Archiv - European Journal of Physiology.

[5]  F. Alkuraya,et al.  Analysis of transcript-deleterious variants in Mendelian disorders: implications for RNA-based diagnostics , 2020, Genome Biology.

[6]  M. Kubota,et al.  Consecutive medical exome analysis at a tertiary center: Diagnostic and health‐economic outcomes , 2020, American journal of medical genetics. Part A.

[7]  Guangyou Duan,et al.  Novel SCN9A missense mutations contribute to congenital insensitivity to pain: Unexpected correlation between electrophysiological characterization and clinical phenotype , 2020, Molecular pain.

[8]  Y. Guan,et al.  Molecular genetic analysis in 21 Chinese families with congenital insensitivity to pain with or without anhidrosis , 2020, European journal of neurology.

[9]  E. Kirkness,et al.  Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging , 2020, Proceedings of the National Academy of Sciences.

[10]  K. Yokochi,et al.  Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy , 2019, Nature Communications.

[11]  Matthew S. Lebo,et al.  Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. , 2019, American journal of human genetics.

[12]  L. Santoro,et al.  A novel SCN9A splicing mutation in a compound heterozygous girl with congenital insensitivity to pain, hyposmia and hypogeusia , 2018, Journal of the peripheral nervous system : JPNS.

[13]  S. Paciga,et al.  Functional confirmation that the R1488* variant in SCN9A results in complete loss-of-function of Nav1.7 , 2018, BMC Medical Genetics.

[14]  J. Vincent,et al.  Biallelic truncating SCN9A mutation identified in four families with congenital insensitivity to pain from Pakistan , 2016, Clinical genetics.

[15]  G. Rouleau,et al.  A novel nonsense mutation in SCN9A in a Moroccan child with congenital insensitivity to pain. , 2014, Pediatric neurology.

[16]  R. Grewal,et al.  Congenital Insensitivity to Pain: A Case Report and Review of the Literature , 2014, Case reports in neurological medicine.

[17]  Yuangan Wu,et al.  Two novel SCN9A gene heterozygous mutations may cause partial deletion of pain perception. , 2011, Pain medicine.

[18]  D. Price,et al.  Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain. , 2011, European journal of pain.

[19]  C. Woods,et al.  Congenital Insensitivity to Pain: Novel SCN9A Missense and In-Frame Deletion Mutations , 2010, Human mutation.

[20]  A. Christiano,et al.  A Nonsense Mutation in the SCN9A Gene in Congenital Insensitivity to Pain , 2010, Dermatology.

[21]  P. Lund,et al.  A stop codon mutation in SCN9A causes lack of pain sensation. , 2007, Human molecular genetics.

[22]  M. Dubé,et al.  Loss‐of‐function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations , 2007, Clinical genetics.

[23]  Hussain Jafri,et al.  An SCN9A channelopathy causes congenital inability to experience pain , 2006, Nature.

[24]  R. Parvari,et al.  A novel mutation in SCN9A in a child with congenital insensitivity to pain. , 2014, Pediatric neurology.